Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
---|---|---|---|---|---|---|---|---|
Jun 27, 2025 | Jul 01, 2025 | Flynn James E 10% | Sell | Ars Pharmaceuticals, Inc. | SPRY | $18.46 | $14M | -7.04% |
Nov 11, 2024 | Nov 14, 2024 | Flynn James E 10% | Sell | Ars Pharmaceuticals, Inc. | SPRY | $18.01 | $10M | -5.08% |
Oct 22, 2024 | Oct 24, 2024 | Flynn James E * Director by Deputization 10% | Sell | Nuvalent, Inc. | NUVL | $97.75 | $196M | -10.00% |
Sep 17, 2024 | Sep 17, 2024 | Flynn James E Possible Members of 10% Group 10% | Buy | Bicara Therapeutics Inc. | BCAX | $18 | $1M | +3.75% |
Mar 08, 2024 | Mar 12, 2024 | Flynn James E *Possible Member of 10% Group 10% | Sell | Adapthealth Corp. | AHCO | $10.9 | $4M | -2.57% |
Feb 16, 2024 | Feb 16, 2024 | Flynn James E * Director by Deputization 10% | Buy | Larimar Therapeutics, Inc. | LRMR | $8.74 | $37M | +16.81% |
Dec 28, 2022 | Dec 31, 2022 | Flynn James E Possible Member of 10% Group 10% | Sell | Oncorus, Inc. | ONCR | $0.26 | $88,254 | -11.46% |
Dec 22, 2022 | Dec 27, 2022 | Flynn James E Possible Member of 10% Group 10% | Sell | Oncorus, Inc. | ONCR | $0.27 | $19,897 | -2.44% |
Dec 19, 2022 | Dec 22, 2022 | Flynn James E *Possible Member of 10% Group 10% | Sell | Oncorus, Inc. | ONCR | $0.29 | $37,628 | -4.09% |
Dec 13, 2022 | Dec 15, 2022 | Flynn James E *Possible Member of 10% Group 10% | Sell | Oncorus, Inc. | ONCR | $0.39 | $5,332 | -0.44% |
Nov 03, 2022 | Nov 07, 2022 | Flynn James E Director by Deputization 10% | Buy | Nuvalent, Inc. | NUVL | $33.5 | $22M | +3.15% |
Sep 16, 2022 | Sep 21, 2022 | Flynn James E * Director by Deputization 10% | Buy | Larimar Therapeutics, Inc. | LRMR | $3.15 | $35M | +39.61% |
Jun 06, 2022 | Jun 08, 2022 | Flynn James E * Possible Member of 10% Group 10% | Sell | Mirum Pharmaceuticals, Inc. | MIRM | $25.01 | $962,256 | -1.17% |
May 10, 2022 | May 10, 2022 | Flynn James E Possible Member of 10% Group 10% | Buy | Pepgen Inc. | PEPG | $12 | $5M | +30.41% |
Oct 26, 2021 | Oct 28, 2021 | Flynn James E Possible Member of 10% Group 10% | Buy | Xilio Therapeutics, Inc. | XLO | $16 | $12M | +25.30% |
Jul 19, 2021 | Jul 21, 2021 | Flynn James E Director by Deputization 10% | Buy | Acutus Medical, Inc. | AFIB | $14 | $15M | +16.52% |
Jul 09, 2021 | Jul 13, 2021 | Flynn James E * Possible Member of 10% Group 10% | Sell | Mirum Pharmaceuticals, Inc. | MIRM | $15.81 | $2M | -2.94% |
Jul 02, 2021 | Jul 07, 2021 | Flynn James E * Possible Member of 10% Group 10% | Sell | Mirum Pharmaceuticals, Inc. | MIRM | $16.29 | $1M | -1.93% |
Jun 30, 2021 | Jul 02, 2021 | Flynn James E * Director by Deputization 10% | Buy | Larimar Therapeutics, Inc. | LRMR | $8.75 | $6M | +10.52% |
Jun 01, 2021 | Jun 03, 2021 | Flynn James E *Possible Member of 10% Group 10% | Buy | Singular Genomics Systems, Inc. | OMIC | $22 | $33M | +14.13% |
May 04, 2021 | May 04, 2021 | Flynn James E Possible Member of 10% Group 10% | Buy | Werewolf Therapeutics, Inc. | HOWL | $16 | $13M | +23.86% |
Mar 30, 2021 | Mar 30, 2021 | Flynn James E Possible Member of 10% Group 10% | Buy | Edgewise Therapeutics, Inc. | EWTX | $16 | $10M | +13.71% |
Feb 17, 2021 | Feb 18, 2021 | Flynn James E *Possible Member of 10% Group 10% | Buy | Oncorus, Inc. | ONCR | $19 | $6M | +8.70% |
Feb 09, 2021 | Feb 09, 2021 | Flynn James E Possible Member of 10% Group 10% | Buy | Terns Pharmaceuticals, Inc. | TERN | $17 | $11M | +21.82% |
Jan 06, 2021 | Jan 08, 2021 | Flynn James E *Possible Member of 10% Group 10% | Sell | Lumos Pharma, Inc. | LUMO | $22.58 | $3M | -16.20% |
Oct 06, 2020 | Oct 08, 2020 | Flynn James E *Possible Member of 10% Group 10% | Buy | Oncorus, Inc. | ONCR | $15 | $15M | +25.98% |
Sep 29, 2020 | Oct 01, 2020 | Flynn James E *Possible Member of 10% Group 10% | Buy | Graybug Vision, Inc. | GRAY | $16 | $25M | +22.83% |
Aug 10, 2020 | Aug 12, 2020 | Flynn James E Director by Deputization 10% | Buy | Acutus Medical, Inc. | AFIB | $18 | $27M | +25.67% |
Jul 28, 2020 | Jul 28, 2020 | Flynn James E Possible Member of 10% Group 10% | Buy | Annexon, Inc. | ANNX | $17 | $12M | +30.20% |
Jul 14, 2020 | Jul 14, 2020 | Flynn James E Possible Member of 10% Group 10% | Buy | Nkarta, Inc. | NKTX | $18 | $18M | +29.24% |
- 1/5
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.